Oral non-viral gene delivery for applications in DNA vaccination and gene therapy

Eric Farris, Kari Heck, Anna T. Lampe, Deborah M. Brown, Amanda E. Ramer-Tait, Angela K. Pannier

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Non-viral gene delivery via the oral route is a promising strategy for improving outcomes of DNA vaccination and gene therapy applications. Unlike traditional parenteral administration routes, the oral route is a non-invasive approach that lends itself to high patient compliance and ease of dosing. Moreover, oral administration allows for both local and systemic production of therapeutic genes or, in the case of DNA vaccination, mucosal and systemic immunity. However, the oral route presents distinct challenges and barriers to achieving successful gene delivery. Oral non-viral gene delivery systems must be able to survive the harsh and variable environments (e.g. acidic pH, degrading enzymes, mucus layer) encountered during transit through the gastrointestinal tract, while still allowing for efficient transgene production at sites of interest. These barriers present unique design challenges for researchers in material selection and in improving the transfection efficiency of orally delivered genes. This review provides an overview of advancements in the design of oral non-viral gene delivery systems, and highlights recent and important developments towards improving orally delivered genes for applications in gene therapy and DNA vaccination.

Original languageEnglish (US)
Pages (from-to)51-57
Number of pages7
JournalCurrent Opinion in Biomedical Engineering
Volume7
DOIs
StatePublished - Sep 2018

Fingerprint

Gene therapy
Genetic Therapy
Vaccination
DNA
Genes
Gene Transfer Techniques
Oral Administration
Mucosal Immunity
Mucus
Patient Compliance
Transgenes
Transfection
Gastrointestinal Tract
Research Personnel
Enzymes

Keywords

  • DNA vaccination
  • Gene therapy
  • Non-viral gene delivery
  • Oral delivery

ASJC Scopus subject areas

  • Bioengineering
  • Biomedical Engineering
  • Biomaterials
  • Medicine (miscellaneous)

Cite this

Oral non-viral gene delivery for applications in DNA vaccination and gene therapy. / Farris, Eric; Heck, Kari; Lampe, Anna T.; Brown, Deborah M.; Ramer-Tait, Amanda E.; Pannier, Angela K.

In: Current Opinion in Biomedical Engineering, Vol. 7, 09.2018, p. 51-57.

Research output: Contribution to journalReview article

@article{3ac940e551fd49f7b43a8cd4b7c0f07a,
title = "Oral non-viral gene delivery for applications in DNA vaccination and gene therapy",
abstract = "Non-viral gene delivery via the oral route is a promising strategy for improving outcomes of DNA vaccination and gene therapy applications. Unlike traditional parenteral administration routes, the oral route is a non-invasive approach that lends itself to high patient compliance and ease of dosing. Moreover, oral administration allows for both local and systemic production of therapeutic genes or, in the case of DNA vaccination, mucosal and systemic immunity. However, the oral route presents distinct challenges and barriers to achieving successful gene delivery. Oral non-viral gene delivery systems must be able to survive the harsh and variable environments (e.g. acidic pH, degrading enzymes, mucus layer) encountered during transit through the gastrointestinal tract, while still allowing for efficient transgene production at sites of interest. These barriers present unique design challenges for researchers in material selection and in improving the transfection efficiency of orally delivered genes. This review provides an overview of advancements in the design of oral non-viral gene delivery systems, and highlights recent and important developments towards improving orally delivered genes for applications in gene therapy and DNA vaccination.",
keywords = "DNA vaccination, Gene therapy, Non-viral gene delivery, Oral delivery",
author = "Eric Farris and Kari Heck and Lampe, {Anna T.} and Brown, {Deborah M.} and Ramer-Tait, {Amanda E.} and Pannier, {Angela K.}",
year = "2018",
month = "9",
doi = "10.1016/j.cobme.2018.09.003",
language = "English (US)",
volume = "7",
pages = "51--57",
journal = "Current Opinion in Biomedical Engineering",
issn = "2468-4511",

}

TY - JOUR

T1 - Oral non-viral gene delivery for applications in DNA vaccination and gene therapy

AU - Farris, Eric

AU - Heck, Kari

AU - Lampe, Anna T.

AU - Brown, Deborah M.

AU - Ramer-Tait, Amanda E.

AU - Pannier, Angela K.

PY - 2018/9

Y1 - 2018/9

N2 - Non-viral gene delivery via the oral route is a promising strategy for improving outcomes of DNA vaccination and gene therapy applications. Unlike traditional parenteral administration routes, the oral route is a non-invasive approach that lends itself to high patient compliance and ease of dosing. Moreover, oral administration allows for both local and systemic production of therapeutic genes or, in the case of DNA vaccination, mucosal and systemic immunity. However, the oral route presents distinct challenges and barriers to achieving successful gene delivery. Oral non-viral gene delivery systems must be able to survive the harsh and variable environments (e.g. acidic pH, degrading enzymes, mucus layer) encountered during transit through the gastrointestinal tract, while still allowing for efficient transgene production at sites of interest. These barriers present unique design challenges for researchers in material selection and in improving the transfection efficiency of orally delivered genes. This review provides an overview of advancements in the design of oral non-viral gene delivery systems, and highlights recent and important developments towards improving orally delivered genes for applications in gene therapy and DNA vaccination.

AB - Non-viral gene delivery via the oral route is a promising strategy for improving outcomes of DNA vaccination and gene therapy applications. Unlike traditional parenteral administration routes, the oral route is a non-invasive approach that lends itself to high patient compliance and ease of dosing. Moreover, oral administration allows for both local and systemic production of therapeutic genes or, in the case of DNA vaccination, mucosal and systemic immunity. However, the oral route presents distinct challenges and barriers to achieving successful gene delivery. Oral non-viral gene delivery systems must be able to survive the harsh and variable environments (e.g. acidic pH, degrading enzymes, mucus layer) encountered during transit through the gastrointestinal tract, while still allowing for efficient transgene production at sites of interest. These barriers present unique design challenges for researchers in material selection and in improving the transfection efficiency of orally delivered genes. This review provides an overview of advancements in the design of oral non-viral gene delivery systems, and highlights recent and important developments towards improving orally delivered genes for applications in gene therapy and DNA vaccination.

KW - DNA vaccination

KW - Gene therapy

KW - Non-viral gene delivery

KW - Oral delivery

UR - http://www.scopus.com/inward/record.url?scp=85064451091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064451091&partnerID=8YFLogxK

U2 - 10.1016/j.cobme.2018.09.003

DO - 10.1016/j.cobme.2018.09.003

M3 - Review article

C2 - 31011691

AN - SCOPUS:85064451091

VL - 7

SP - 51

EP - 57

JO - Current Opinion in Biomedical Engineering

JF - Current Opinion in Biomedical Engineering

SN - 2468-4511

ER -